Related Experiment Video
Updated: Jun 16, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Vitamin K prophylaxis for preterm infants
1Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom. paul.clarke@nnuh.nhs.uk
Insights
Vitamin K prophylaxis is standard for preterm infants, but optimal dosage and status assessment need more research. Current practices vary widely, highlighting a need for standardized, evidence-based guidelines.
Area of Science:
- Neonatal medicine
- Pediatric pharmacology
- Biochemistry
Background:
- Vitamin K prophylaxis is a routine treatment for preterm infants worldwide.
- Despite widespread use, optimal dosage and administration methods remain unclear.
- Limited research exists on vitamin K status post-prophylaxis in this vulnerable population.
Purpose of the Study:
- To review current vitamin K prophylaxis practices in preterm infants.
- To identify gaps in knowledge regarding optimal dosing and status assessment.
- To highlight the need for evidence-based guidelines for vitamin K administration.
Main Methods:
- Literature review of existing studies on vitamin K prophylaxis in preterm neonates.
- Analysis of current clinical practices and guidelines.
- Identification of research gaps and areas for future investigation.
Main Results:
- Significant variability exists in current vitamin K prophylaxis regimens (dose, route, formulation).
- There is a lack of data on the long-term vitamin K status of preterm infants post-prophylaxis.
- Current practices are not consistently based on refined, population-specific evidence.
Conclusions:
- Standardization of vitamin K prophylaxis for preterm infants is warranted.
- Further research is crucial to determine optimal dosing and assess vitamin K status.
- Evidence-based guidelines are needed to ensure safe and effective vitamin K administration.
Abstract:
Vitamin K is the most common 'drug' administered to babies born in the western world. For many decades vitamin K prophylaxis has been a routine treatment at birth for preterm infants. Despite universal use in preterm infants, very little work has been done to date to refine vitamin K dosage in this population or to assess vitamin K status after prophylaxis. Current regimens of prophylaxis used for preterm infants vary widely in terms of dose, route of administration, and formulation used.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...

